Yanyan Zhuang - Publications

Serial PNA-Transformer-Based Virtual Screening Identifies Nanomolar DYRK1A Inhibitors for Pancreatic Ductal Adenocarcinoma.

Journal: ACS medicinal chemistry letters

Published: December 03, 2025

Risk factors and rechallenge outcomes in severe immune-mediated hepatotoxicity: Real-world evidence from two high-volume centers in China.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 19, 2025

DeepMetabio-mCRC Screener: A Multi-Omics Deep Learning Framework for Early Risk Prediction and Biomarker Discovery in Colorectal Liver Metastasis.

Journal: Computational and structural biotechnology journal

Published: October 22, 2025

S100A6 promotes liver metastasis by activating FGFR3 signaling in BAP1-deficient uveal melanoma.

Journal: Oncogene

Published: October 01, 2025

Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2" [GENE 927C (2024) 148739].

Journal: Gene

Published: September 21, 2024

tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2.

Journal: Gene

Published: January 29, 2024

Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinoma.

Journal: Cancer gene therapy

Published: December 26, 2023

Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis.

Journal: Molecular cancer

Published: November 11, 2022

Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment.

Journal: Cancers

Published: September 10, 2022

Primary Esophageal Lymphoma: Clinical Experience in Diagnosis and Treatment.

Journal: Cureus

Published: August 31, 2021

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma.

Journal: Frontiers in cell and developmental biology

Published: August 15, 2021

CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma.

Journal: Cell death discovery

Published: July 02, 2021